ORGANIC
LETTERS
2013
Vol. 15, No. 6
1178–1181
Syntheses of the C1ÀC14 and C15ÀC25
Fragments of Amphidinolide C
Dimao Wu and Craig J. Forsyth*
Department of Chemistry and Biochemistry, The Ohio State University, Columbus,
Ohio 43210, United States
Received December 21, 2012
ABSTRACT
Divergent syntheses of the C1ÀC14 and C15ÀC25 fragments of amphidinolide C have been achieved. The synthesis of the C15ÀC25 fragment
featured cobalt-catalyzed modified Mukaiyama aerobic alkenol cyclization and sulfur-directed regiocontrolled Wacker oxidation of an internal
alkene. The C1ÀC14 fragment was established by alkenyllithium addition to an aldehyde followed by a challenging olefination of a highly inert
C9 ketone.
The amphidinolides represent a large family of marine
natural products with 34 structurally varied members.
They have been isolated from symbiotic dinoflagellates
Amphidinium sp. associated with the Okinawan aceol flat-
worm Amphiscolops sp.1 Among them, the amphidinolide
C subgroup including amphidinolide C (1, from Y-5, Y-56
and Y71 strain), C2 (2, from Y71 strain), C3 (3, from Y56
strain), and F (4, from Y56 strain) share an identical
25-membered macrolide moiety with different aliphatic poly-
ene substructures attached (Figure 1).2 Intriguingly, their
antitumor activities were highly related to the tail polyene
domain, especially the C29 oxidation state. Bearing a free
C29ÀOH, amphidinolide C (1) was the only subgroup
member displaying remarkable in vivo cytotoxicity with
IC50’s below 10 ng/mL. Since the stereochemistry of 1 was
fully elucidated in 2001À2003,3 significant synthetic efforts
have been made toward amphidinolide C and related
macrolides, including a recently reported total synthesis
of amphidinolide F.4 Herein we report synthetic progress
toward 1, focusing on the syntheses of the C1ÀC14 and
C15ÀC25 fragments.
To facilitate the generation of analogues to support
structureÀactivity relationship studies, a late-stage instal-
lation of the C26ÀC34 polyene domain after establishing
the C1ÀC25 macrolide was planned (Figure 1). Retro-
synthetically, the macrolide was disconnected at the C1
(3) (a) Kubota, T.; Tsuda, M.; Kobayashi, J. Org. Lett. 2001, 3, 1363.
(b) Kubota, T.; Tsuda, M.; Kobayashi, J. Tetrahedron 2003, 59, 1613.
(4) (a) Shotwell, J. B.; Roush, W. R. Org. Lett. 2004, 12, 3865. (b)
Bates, R. H.; Shotwell, J. B.; Roush, W. R. Org. Lett. 2008, 9, 4343. (c)
Mahapatra, S.; Carter, R. G. Org. Biomol. Chem. 2009, 7, 4582. (d)
Mahapatra, S.; Carter, R. G. Angew. Chem., Int. Ed. 2012, 51, 7948. (e)
(1) For recent reviews, see: (a) Kobayashi, J.; Ishibashi, M. Chem.
Rev. 1993, 93, 1753. (b) Chakraborty, T. K.; Das, S. Curr. Med. Chem.
2001, 1, 131. (c) Kobayashi, J.; Kubota, T. J. Nat. Prod. 2007, 70, 451. (d)
Kobayashi, J. J. Antibiot. 2008, 61, 271.
(2) (a) Amphidinolide, C.; Kobayashi, J.; Ishibashi, M.; Walchli,
M. R.; Nakamura, H.; Hirata, Y.; Sasaki, T.; Ohizumi, Y. J. Am. Chem.
Soc. 1988, 110, 490. (b) Amphidinolide C2: Kubota, T.; Sakuma, Y.;
Tsuda, M.; Kobayashi, J. Mar. Drugs 2004, 2, 83. (c) Amphidnolide C3:
Kubota, T.; Suzuki, A.; Yamada, M.; Baba, S.; Kobayashi, J. Hetero-
cycles 2010, 82, 333. (d) Amphidinolide, F.; Kobayashi, J.; Tsuda, M.;
Ishibashi, M.; Shigemori, H.; Yamasu, T.; Hirota, H.; Sasaki, T.
J. Antibiot. 1991, 44, 1259.
ꢀ
ꢁ
Ferrie, L.; Figadere, B. Org. Lett. 2010, 12, 4976. (f) Paudyal, M. P.;
Rath, N. P.; Spilling, C. D. Org. Lett. 2010, 12, 2954. (g) Roy, S.;
Spilling, C. D. Org. Lett. 2010, 12, 5326. (h) Morra, N. A.; Pagenkopf,
B. L. Org. Lett. 2011, 13, 572. (i) Mohapatra, D. K.; Rahaman, H.;
Chorghade, M. S.; Gurjar, M. K. Synlett 2007, 567. (j) Mohapatra,
D. K.; Dasari, P.; Rahaman, H.; Pal, R. Tetrahedron Lett. 2009, 50,
6276. (k) Fultz, M. W. Progress Towards the Total Synthesis of
Amphidinolide C. Ph.D. Dissertation, Indiana University, Bloomington,
IN, 2009.
r
10.1021/ol303515h
Published on Web 02/26/2013
2013 American Chemical Society